All news

HealthEquity adds Moody's CFO to board as revenue rises

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

HealthEquity reported Q2 fiscal 2027 revenue of USD 350.73 million, up 7.6 percent year-over-year, and raised its fiscal 2027 revenue guidance. The company appointed Moody's CFO Noémie Heuland to its board effective September 24, 2026, adding finance and technology expertise. Shares traded at USD 90.04 on October 2, 2026, down 16.34 percent from their 52-week high. Analysts hold a Moderate Buy rating with an average price target of USD 112.20.

Read original source

HQY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.